Approval · Notice of Compliance 36614 · 2025
TRAZIMERA: Notice of Compliance 36614
Issued December 23, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36614
- Date
- December 23, 2025
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph
- Canadian reference product
- HERCEPTIN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRAZIMERA | Not yet assigned | — |
Medicinal ingredients
- TRASTUZUMAB 440 MG per VIAL
- TRASTUZUMAB 150 MG per VIAL